Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Cash & Equivalents (2016 - 2025)

Neogen (NEOG) has 16 years of Cash & Equivalents data on record, last reported at $145.3 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 3.64% year-over-year to $145.3 million; the TTM value through Nov 2025 reached $145.3 million, up 3.64%, while the annual FY2025 figure was $129.0 million, 24.39% down from the prior year.
  • Cash & Equivalents reached $145.3 million in Q4 2025 per NEOG's latest filing, up from $138.9 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $205.8 million in Q4 2023 and bottomed at $42.9 million in Q1 2022.
  • Average Cash & Equivalents over 5 years is $115.7 million, with a median of $124.1 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: tumbled 55.11% in 2021, then skyrocketed 267.05% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $51.1 million in 2021, then soared by 95.62% to $100.0 million in 2022, then soared by 105.76% to $205.8 million in 2023, then plummeted by 31.85% to $140.2 million in 2024, then rose by 3.64% to $145.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $145.3 million in Q4 2025, $138.9 million in Q3 2025, and $129.0 million in Q2 2025.